* Portola pharmaceuticals receives complete response letter
from fda for biologics license application for andexxa(tm)
(andexanet alfa)
The post CORRECTED-BRIEF-Portola Pharmaceuticals receives Complete Response Letter from FDA for biologics license application for AndexXa appeared first on NASDAQ.